An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

Trial Profile

An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Nov 2016

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV-1 infections
  • Focus Expanded access; Therapeutic Use
  • Sponsors ViiV Healthcare
  • Most Recent Events

    • 08 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 19 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 31 Jan 2013 Planned end date changed from 23 May 2014 to 1 Jan 2020 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top